This website uses non-intrusive cookies to improve your user experience. You can visit our cookie privacy page for more information.

Advisory Committee on Dangerous Pathogens (ACDP): Work plan for 2009/2010

  1. To formulate a common set of containment measures to apply to animal and human pathogens[i], following the review of the regulatory framework for animal pathogens (Callaghan review).
  2. To advise the Department of Health on the type of isolation facilities to be provided within the NHS.
  3. To maintain oversight of the work plan of the ACDP TSE Working Group.
  4. To complete the revision of the ACDP 1996 Guidance: ‘Management and Control of Viral Haemorrhagic Fevers’.
  5. To consider the re-categorisation of Polio virus – dependent on the progress of the global polio eradication programme.
  6. To develop additional guidelines to add to existing ACDP advice on working with influenza viruses of known pandemic potential, in conjunction with the Scientific Advisory Committee for Genetic Modification.
  7. To draft additional guidance on working with Neisseria meningitidis

Note

  1. As a minimum this will involve revision of ‘The Management, Design & Operation of Microbiological Containment Laboratories’ and ‘The Principles, Design & Operation of Containment Level 4 Laboratories’

Advisory Committee on Dangerous Pathogens TSE Working Group: Work Plan 2009/2010

  1. To review and update as necessary the current TSE guidance[1] (Parts 2, 3 and 4, and Annexes C and H are currently under revision and nearing completion)
  2. In conjunction with the work of ESAC-Pr[2] , to consider and draft relevant guidance when necessary on the handling and disposal of single-use surgical instruments
  3. To re-write Annex G of the TSE guidance[1] on specialist equipment
  4. To continue to promote the TSE guidance[1] to healthcare and research workers, through their professional bodies and at relevant conferences
  5. To respond to any policy issues arising from consideration of recent HPA dentistry studies
  6. To address issues of risk management as they arise

Notes

  1. The TSE guidance referred to above is the “Transmissible spongiform encephalopathy agents: safe working and the prevention of infection”. The guidance was published in 2003 but individual sections are revised as further scientific information becomes available or future policy decisions need to be reflected.
  2. ESAC-Pr – The Engineering & Science Advisory Committee into the Decontamination of Surgical Instruments including Prion Removal
Updated 2009-05-19